Sasiwimol Ubolyam

Thai Red Cross Society — Thailand

Immunology and Microbiology · Life Sciences

30h-index3.1kcitations140works4.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(77), HIV/AIDS Research and Interventions(60), HIV/AIDS drug development and treatment(49), HIV-related health complications and treatments(32), Pneumocystis jirovecii pneumonia detection and treatment(16)

Publications138 total

The Association Between Genetic Polymorphisms of UGT1A1, ABCG2, and NR1I2 and Dolutegravir Pharmacokinetic Parameters in Thai People Living with HIV
Pharmaceutics·2025Open Access
Pharmacokinetics and tolerability of one-month daily rifapentine for latent tuberculosis treatment in haemodialysis patients
Journal of Antimicrobial Chemotherapy·2025
<i>NAT</i> 2 Polymorphisms and Antituberculosis-Induced Hepatotoxicity in Thai People Living With HIV: Insights From a Pharmacogenetic–Pharmacokinetic Cohort Study
The Journal of Infectious Diseases·2025
The impact of the toll-like receptor 1 (TLR1) variation rs5743557 on tuberculosis susceptibility in the Thai population
Journal of Thoracic Disease·2025Open Access
Immunogenicity and safety of ‘Comvigen’, a bivalent SARS-CoV-2 vaccine, in comparison to Comirnaty bivalent vaccine in Thailand: a phase 2, non-inferiority randomised trial
The Lancet Regional Health - Southeast Asia·2025Open Access
Conference proceedings from the 27th Bangkok International Symposium on HIV medicine
Future Virology·2025
Differential immunogenicity in people living with HIV with varying CD4 levels after bivalent mRNA COVID-19 booster vaccination
PLoS ONE·2025Open Access
Urine-Xpert Ultra for the diagnosis of tuberculosis in people living with HIV: a prospective, multicentre, diagnostic accuracy study
The Lancet Global Health·2024· 10 citedOpen Access
The population pharmacokinetics of dolutegravir co‐administered with rifampicin in Thai people living with <scp>HIV</scp>: Assessment of alternative dosing regimens
CPT Pharmacometrics & Systems Pharmacology·2024· 3 citedOpen Access
Strengthening the Application of the DAIDS GCLP Guidelines: The Implementation of an Integrated Laboratory Oversight Framework
AIDS Research and Human Retroviruses·2024Open Access
A Prospective Evaluation of the Diagnostic Accuracy of the Point-of-Care VISITECT CD4 Advanced Disease Test in 7 Countries
The Journal of Infectious Diseases·2024· 11 citedOpen Access
Prospective multicentre accuracy evaluation of the FUJIFILM SILVAMP TB LAM test for the diagnosis of tuberculosis in people living with HIV demonstrates lot-to-lot variability
PLoS ONE·2024· 24 citedOpen Access
The plasma kynurenine-to-tryptophan ratio as a biomarker of tuberculosis disease in people living with HIV on antiretroviral therapy: an exploratory nested case–control study
BMC Infectious Diseases·2024· 7 citedOpen Access
Framingham risk score based vascular outcomes in acute versus chronic <scp>HIV</scp> cohorts after 6 years of <scp>ART</scp>
HIV Medicine·2024· 2 citedOpen Access
Phase II prefusion non-stabilised Covid-19 mRNA vaccine randomised study
Scientific Reports·2024· 9 citedOpen Access
Conference Proceedings From the 26th Bangkok International Symposium on HIV Medicine
Future Virology·2024Open Access
Trajectory of cognitive performance among virologically suppressed aging people living with HIV
Alzheimer s & Dementia·2023Open Access
Impact of steatotic liver disease and non‐alcoholic steatohepatitis on cognitive impairment in people living with <scp>HIV</scp>: A cross‐sectional study
HIV Medicine·2023· 1 citedOpen Access
Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis With Liver Fibrosis as Predictors of New-Onset Diabetes Mellitus in People With HIV: A Longitudinal Cohort Study
Clinical Infectious Diseases·2023· 20 citedOpen Access
Metabolic‐Associated Fatty Liver Disease (<scp>MAFLD</scp>) is associated with immune activation, increased epicardial fat volume, and steatohepatitis among people with <scp>HIV</scp> in a Thai cohort
HIV Medicine·2023· 3 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Kiat Ruxrungtham(29), Jintanat Ananworanich(24), Praphan Phanuphak(23), Suteeraporn Pinyakorn(13), Anchalee Avihingsanon(12), Eugène Kroon(11), Nittaya Phanuphak(11), Nelson L. Michael(10), Sunee Sirivichayakul(10), Merlin L. Robb(9), Stephen J. Kerr(9), David A. Cooper(9), Joep M. A. Lange(8), Nitiya Chomchey(7), Mark de Souza(7), Siriwat Akapirat(7), Carlo Sacdalan(7), Rapee Trichavaroj(6), Nicolas Chomont(6), Bernard Hirschel(6)